HOME Research Insight Market Leader - Adhesion Barrier Market

Market Leader - Adhesion Barrier Market

The global adhesion barriers market is projected to reach USD 806.4 Million by 2023 from USD 570.7 Million in 2018, at a CAGR of 7.2%. The global adhesion barriers market is fragmented with various regional and multinational market players. In 2017, Sanofi (France), Johnson & Johnson (J&J) (US), and Baxter International (US) dominated the adhesion barriers market. These players together accounted for 84–85% of market share.

Sanofi (France) dominated the global adhesion barriers market with the largest share in 2017. The company offers the “Seprafilm” product which is one of the top-selling brands in the global adhesion barriers market for gynecological/pelvic and abdominal/general surgeries. Sanofi’s leading position in the market is attributed to its strong manufacturing and distributing capabilities—the company has 400 subsidiaries present across the globe.

The company primarily pursues the strategies of customer relationship management and maintaining brand value to garner a large market share. The overall revenue growth of the company is 3.6% between 2016 and 2017; however, there is a decline in the revenue growth of the company’s pharmaceutical business segment due to the decline in sales of the US.

Johnson & Johnson (J&J) held the second position in the global adhesion barriers market in 2017. The company’s product, GYNECARE INTERCEED, is one of the most widely used brands for gynecological surgeries, globally. The company’s stronghold in the global adhesion barriers market is largely attributed to its high brand value and strong geographic presence across the globe, covering North America, Europe, the Middle East & Africa, and Asia Pacific. The company also has a strong distribution network globally, with more than 250 subsidiaries. Expansion is a key strategy for J&J in the global adhesion barriers market. For instance, in April 2014, its subsidiary Ethicon Biosurgery Ireland invested USD 106.4 million in a new manufacturing facility in Limerick.

Baxter International (US) is another well-established player in the global adhesion barriers market. The company provides the ADEPT adhesion prevention solutions, which is a widely used liquid adhesion barrier for gynecological surgeries and general/abdominal surgeries. The company’s major strengths lie in its strong presence across the globe, brand name, and wide product portfolio. The company’s strong presence and its worldwide sales channel in approximately 100 countries will ensure its future growth in the adhesion barriers market. The high growth potential in developing regions offers significant growth opportunities for the company. It generates most of its revenue from developed regions such as North America and some of the European countries.

Some of the other players competing in this market are C.R. Bard (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll Holdings (Ireland), Betatech Medical (Turkey), SyntheMed (US), Aziyo Biologics (US), Biom’up (France), Terumo Corporation (Japan), and BMI Korea Co. (South Korea).

Related Reports:

Adhesion Barrier Market by Product (Regenerated Cellulose, Hyaluronic Acid, Polyethylene Glycol, Fibrin, Collagen & Protein), Type (Film, Gel, Liquid), Application (Abdominal, Orthopedic, Cardiovascular, Gynecological Surgery) - Global Forecast to 2023

Mr. Rohan
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA : 1-888-600-6441 

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support

US : 1-888-600-6441

Search reports